Sterlington Advises Humata Health Founder and CEO on Acquisition by R1

NEW YORK--(BUSINESS WIRE)--

Sterlington is advising Jeremy Friese, MD, Founder and Chief Executive Officer of Humata Health (Humata) in connection with the company’s acquisition by R1 RCM Inc., a leader in healthcare revenue management.

Sterlington is advising the CEO on all aspects of the transaction. Humata is a leading health tech company providing AI-powered, touchless prior authorization solutions for health systems, payers, and patients. Its mission is to make prior authorization easy and seamless for providers, payers, and patients.

The Sterlington team was led by Executive Compensation partner Jeremy Goldstein, Corporate partner Christopher Harrison, Executive Compensation partner Audry Casusol, and Corporate partner Michael Gilligan.

This transaction marks Sterlington's latest healthcare-sector engagement, following Designs for Health, Florida Cancer Specialists & Research Institute, and Avanos Medical.

About Sterlington

Sterlington PLLC is a full-service law firm focusing on complex corporate, litigation, executive compensation, and private wealth matters. As a firm, we focus on the economic as well as the legal aspects of our matters.

Among other strengths, Sterlington is the ultimate law firm for founders, senior executives, and UHNWIs as well as their related businesses.

Visit us at www.sterlingtonlaw.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260819578582/en/

Amanda Sims
Communications Manager
Sterlington
[email protected]

Source: Sterlington PLLC

You May Also Be Interested In

• Mercialys: Number of Outstanding Shares and Voting Rights as of August 31, 2026
• Klutch Cannabis Announces Acquisition of Second Columbus Dispensary in Grandview; Relocation of Tallmadge Store to New Flagship Location in Akron
• Leading Chinese Virtual Artist KONG Successfully Concludes “Trace” Fan Meeting in Shanghai